Status:
COMPLETED
Alpha Lipoic Acid and Insulin Resistance
Lead Sponsor:
University of California, San Francisco
Conditions:
Insulin Resistance
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
Subjects will be screened with a 2 hour oral glucose tolerance test. After this screening visit, their insulin resistance will be measured. Subjects will then be given either alpha lipoic acid (antiox...
Detailed Description
We propose to perform a placebo-controlled study of Alpha Lipoic Acid (LA) administration in a cohort of non-obese, non-diabetic, insulin resistant subjects. The insulin sensitivity of 180 subjects wi...
Eligibility Criteria
Inclusion
- Healthy, not exercising regularly
Exclusion
- Diabetes, Impaired glucose tolerance, Heart disease, Liver disease, HIV, abnormal TSH results, other abnormal lab values
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT00845156
Start Date
January 1 2008
End Date
September 1 2010
Last Update
June 20 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California at San Francisco
San Francisco, California, United States, 94143